New approaches to inflammatory bowel disease: the role of the microbiome and Faecalibacterium prausnitzii

Inflammatory bowel disease (IBD), including ulcerative colitis и Crohn's disease, are chronic conditions that can significantly impair quality of life. They are characterised by persistent inflammation of the intestinal mucosa leading to symptoms such as diarrhoea, pain, bleeding and fatigue.

In recent years, science has turned its attention to the gut microbiome as a key factor in the development and treatment of these diseases.

What is the role of the microbiome in IBD

The gut microbiome is a complex ecosystem of bacteria involved in:

• regulation of the immune system
• the maintenance of the intestinal barrier
• the control of inflammatory processes

In patients with ulcerative colitis and Crohn's disease, it is often seen dysbiosis - disturbed balance of intestinal bacteria.

What is Faecalibacterium prausnitzii

One of the most studied „beneficial“ bacteria is Faecalibacterium prausnitzii - a type that is usually abundant in healthy people but is often reduced in patients with inflammatory bowel disease.

This bacterium is related to:

• anti-inflammatory effects
• maintenance of the intestinal barrier
• production of important metabolites

Mechanism of action: why this bacterium is important

Faecalibacterium prausnitzii produces butyrate - a short-chain fatty acid that:

• serves as the main energy source for the cells of the intestine
• supports the recovery of intestinal mucosa
• reduces inflammatory processes

In addition, it participates in:

• strengthening the intestinal barrier
• stimulation of regulatory T-cells (key for control of the immune response)

What the latest research shows

Contemporary clinical research is examining the possibility of restoration of this bacteria through targeted therapies.

The results show:

• improvement of symptoms in some patients
• reduction of inflammation
• better microbiome balance

Although the data are promising, it is important to highlight:

- these approaches are still evolving
- do not replace standard treatment
- require individual medical assessment

How this relates to fecal microtransplantation (FMT)

One way to restore missing bacteria in the microbiome is by fecal microbiota transplantation (FMT).

FMT aims to:

• to restore the overall microbiome balance
• to introduce beneficial bacteria, including such as Faecalibacterium prausnitzii
• to help reduce inflammation

This approach is being actively investigated in patients with IBD.

The future: personalized microbiome medicine

Increasingly, the concept of personalized medicine is evolving, where:

• the individual microbiome is analysed
• missing or reduced bacteria are identified
• targeted therapies are applied

This may include:

• specific probiotics
• microbiome therapies
• FMT in appropriate cases

When to seek advice

If you suffer from:

• ulcerative colitis
• Crohn's disease
• chronic intestinal symptoms

and standard treatment does not give the desired result, it may be useful to discuss the possibilities of a microbiome approach with a specialist.

Conclusion

Restoring the gut microbiome, including bacteria such as Faecalibacterium prausnitzii, is one of the most promising directions in modern medicine. Although these therapies are still in development, they open up new possibilities for a more holistic and individualized approach to inflammatory bowel disease.

Source: https://pubmed.ncbi.nlm.nih.gov/41553310/